Norton Rose Fulbright’s survey found 53% of healthcare industry counsel said AI exposure across clinical and operational functions has increased at the federal level.
Norton Rose Fulbright’s survey found 53% of healthcare industry counsel said AI exposure across clinical and operational functions has increased at the federal level.

